American Herbal Products Association (AHPA) > About Us > Committees > Government Relations Committee

Government Relations Committee

Chairperson: Staci Eisner (Cortex Scientific)
Staff Contact: Michael McGuffin

Committee Purpose: To monitor legislative and regulatory issues and agencies for the purpose of developing industry positions that conform to AHPA's mission.

AHPA Members, if you would like to join this committee, please email the staff contact.

 

Committee Meeting Minutes

March 7, 2019 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

January 15, 2016 Meeting Minutes

Government Relations Committee meeting minutes

AHPA Members log in to download the meeting minutes

RSS

Committee-Related News

AHPA Continuity of Service To Our Members

AHPA services and commitment to shared goals continue during COVID-19 outbreak

As we all try to adapt to rapid changes, please note that the services AHPA provides and the commitment we share with you to our mission to support responsible commerce in herbal products will not change. We are taking precautions in response to this current emergency, so AHPA’s staff are now all working remotely. Each of us can be reached at our normal phone numbers and email addresses (see here).

March 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The March 2020 AHPA Report includes a discussion of proposals to make supplement regulation more efficient and effective, the Cannabis Committee's 10-year anniversary, AERs and supplement safety, postponed events and an update on international supplement regulation from IADSA.

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

For 10 years AHPA’s Cannabis Committee has been actively involved in the regulatory, legislative, and technical aspects of moving cannabis (including hemp-CBD) into the legal marketplace

Silver Spring, MD – The American Herbal Products Association (AHPA), the voice of the herbal products industry, celebrates the 10-year anniversary of its Cannabis Committee today. The Committee was established on March 10, 2010 to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species, including hemp and hemp-derived cannabidiol (CBD).
Adverse Event Reporting Tells the Story of Dietary Supplement Safety

Adverse Event Reporting Tells the Story of Dietary Supplement Safety

FDA AER data often lacks fields that may prevent misinterpretation, including FDA’s assessment of causation

Washington, D.C. — At the initial Congressional Dietary Supplement Caucus briefing of 2020, held last week, Dr. Richard Kingston, president, regulatory and scientific affairs and co-founder of SafetyCall International, educated congressional staffers on the types of evidence used to monitor dietary supplement safety, including adverse event reports, emergency room visits and poison control center data. Dr. Kingston is an expert on clinical toxicology and pharmacology, poison control, product post-market surveillance, and drug and dietary supplement safety.

February 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The February 2020 AHPA Report includes a look at the recent U.S.-China trade agreement, the impact of the Coronavirus on the industry, AHPA's comments to USDA on the domestic hemp product program and the final schedule of AHPA Events at Expo West 2020.

AHPA submits comments to USDA on domestic hemp production program

Significant room for improvement in the hemp production Interim Final Rule and the subsequent Final Rule

In comments submitted to U.S. Department of Agriculture (USDA), Agricultural Marketing Service (AMS), AHPA requested numerous, significant revisions to the Interim Final Rule (IFR) that establishes a domestic hemp production program before a Final Rule is promulgated in 2021.

“Phase One” agreement with China provides some relief to supplement importers

Reduced tariffs will affect imports filed after February 14

A partial trade agreement signed by the United States and China on January 15, 2020, will reduce U.S.-imposed tariffs on some imported Chinese goods used by U.S. dietary supplement and food companies, but it will leave tariffs on other commodities in place, at least for the short term.

January 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The January 2020 AHPA Report includes class action claims reinstated on “adulterated” supplements, AHPA Events at Expo West 2020, McGuffin named Industry Leader by Nutritional Outlook, and the 2020 Hemp-CBD Supplement Congress.

Dietary Supplements Regulatory Summit

Dietary Supplements Regulatory Summit

POSTPONED

The annual Dietary Supplements Regulatory Summit (DSRS) was scheduled to take place May 27 in Washington, D.C. has been postponed. A new date is being scheduled,

December 2019 AHPA Report: Looking back at 2019 and forward to 2020

December 2019 AHPA Report: Looking back at 2019 and forward to 2020

AHPA Members, Log in to access the AHPA Report

The December 2019 AHPA Report includes a look back at 2019 and forward to 2020, Class action claims reinstated on “adulterated” supplements, AHPA Events at Expo West 2020, McGuffin named Industry Leader by Nutritional Outlook, and the 2020 Hemp-CBD Supplement Congress.

RSS
123456789